and suppressing the integrin β1/transforming growth factor-beta (TGFβ) signaling pathway. A new study by researchers from Harbin Medical University, in China, provides insights into the ...

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple ...

The role of immune regulatory and regenerative signals, particularly TGF-β, is of interest ... at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in ...